- MFCD01753356
- Q-100319
- NSC-823867
- HMS3712F15
- UNII-WT0YJV846J
- Catharantine
- Methyl (2alpha,5beta,6alpha)-3,4-didehydroibogamine-18beta-carboxylate
- AC-34053
- BRD-K92377961-001-03-7', "(6R,6aR,9R,11R)-Methyl 7-ethyl-6,6a,9,10,12,13-hexahydro-5H-6,9-methanopyrido[1',2':1,2]azepino[4,5-b]indole-6-carboxylate", "(6R,6aR,9R,11R)-Methyl7-ethyl-6,6a,9,10,12,13-hexahydro-5H-6,9-methanopyrido[1',2':1,2]azepino[4,5-b]indole-6-carboxylate", 'Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2-alpha,5-beta,6-alpha,18-beta)-
- BRD-K92377961-001-02-9
- CHEMBL2163793
- Catharanthine Base
- HMS3885K13
- Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2alpha,5beta,6alpha,18beta)-
- CHEBI:3469
- HMS3652A13
- SW198653-2
- CCG-220187
- 2468-21-5
- EINECS 219-586-6
- (+)-Catharanthine
- AKOS024463388
- BDBM50396009
- Catharanthine (free base)
- s3202
- HMS2095F15
- (+)-3,4-Didehydrocoronaridine
- NSC823867
- Methyl (2-alpha,5-beta,6-alpha,18-beta)-3,4-didehydroibogamine-18-carboxylate
- Catharanthine, (+)-
- CATHARANTHINE [MI]
- NS00018340
- AB01566866_01
- WT0YJV846J
- DTXSID80947621
- IBOGAMINE-18-CARBOXYLIC ACID, 3,4-DIDEHYDRO-, METHYL ESTER,(2.ALPHA.,5.BETA.,6.ALPHA.,18.BETA.)-
- 1ST168797
- Catharanthine, >=95% (HPLC)
- methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate
- Catharanthin
- Catharanthine
|